← Open Payments lookup

BELINDA MILLER: Open Payments

NPI 1295021053 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,014 in 44 payments from 9 companies in 2025. Trend: 2023 $1,117 · 2024 $1,172 · 2025 $1,014

Food & beverage: $1,014
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$379
Alkermes, Inc.9$188
Otsuka America Pharmaceutical, Inc.8$175
Lundbeck LLC5$98
E.R. Squibb & Sons, L.L.C.3$67
Teva Pharmaceuticals USA, Inc.2$52
Janssen Pharmaceuticals, Inc1$27
ABBVIE INC.1$14
Luye Pharma (USA) Ltd.1$14

Products named: INGREZZA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, UZEDY, SPRAVATO, ABILIFY MAINTENA, VRAYLAR.

Industry payments across LA — which companies pay providers there.